MedPath

Differences in Pain Processing Between Men and Women

Not Applicable
Completed
Conditions
Central Sensitisation
Interventions
Other: Cutaneous thermal stimuli
Registration Number
NCT05031286
Lead Sponsor
Balgrist University Hospital
Brief Summary

Many chronic pain conditions show clear differences between between men and women, such as reported pain intensities or treatment effects, with chronic pain conditions being generally more frequent in women. Yet, the underlying mechanisms causing these differences are poorly understood. Central sensitization (CS) is considered one important mechanism in pain patients which differs between female and male patients. The central hypothesis is that already in the healthy population CS processes are more pronounced in women than in men.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
66
Inclusion Criteria
  • good general health
  • able to give informed consent
Exclusion Criteria
  • pain complaints for more than two consecutive days over the past three months
  • any major medical or psychiatric condition (e.g. heart disease, major depressive disorder)
  • any chronic pain condition
  • inability to follow study instructions
  • consumption of stimulants, drugs, or analgesics within the past 24 hours
  • scar tissue or generally reduced sensitivity in the designated testing site areas

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Experimental ArmCutaneous thermal stimuli-
Primary Outcome Measures
NameTimeMethod
Change in spatial extent of mechanical hypersensitivity after intervention w.r.t. baseline10-20 minutes before intervention (baseline) and 20-30 minutes after intervention

Mapping of hypersensitivity in cm2 of sensitized skin area using two quantitative sensory testing tools (256mN von Frey filament and 200-400mN brush) before and after intervention

Changes to the nociceptive withdrawal reflex (NWR) after intervention w.r.t. baseline5-10 minutes before intervention (baseline) and 30-35 minutes after intervention

Repetitive suprathreshold elicitation of the NWR to monitor its characteristics (such as magnitude and number of responses) before and after intervention

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Balgrist Campus

🇨🇭

Zürich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath